Literature DB >> 20888414

Sp7/Osterix is involved in the up-regulation of the mouse pro-α1(V) collagen gene (Col5a1) in osteoblastic cells.

Yun-Feng Wu1, Noritaka Matsuo, Hideaki Sumiyoshi, Hidekatsu Yoshioka.   

Abstract

Sp7/Osterix, a transcription factor whose expression is restricted in osteoblasts, belongs to the Sp family of transcription factor that bind to G/C-rich sequences. Previous studies have identified a Sp1binding site in the proximal promoter region of the mouse Col5a1 gene, but it did not activate or repress this gene in a mouse fibroblast cell line and a human rhabdomyosarcoma cell line. The purpose of the present study was to clarify the involvement of Sp7/Osterix in the mouse Col5a1 gene. A functional analysis revealed that mutation of the Sp1 binding site specifically decreased the promoter activity in osteoblastic cells. An overexpression of Sp7/Osterix significantly increased the promoter activity and the endogenous mRNA levels of the Col5a1 gene in osteoblastic cells. Conversely, siRNA-mediated knockdown of Sp7/Osterix decreased the promoter activity and the endogenous mRNA levels of the Col5a1 gene. These effects on promoter activity were canceled when the mutant construct of Sp1 binding site was introduced. Consistent with these data, the experiments using an osteoblast differentiation model showed increased promoter activity and endogenous mRNA levels, along with increased Sp7/Osterix during differentiation. Therefore, type V collagen appears to be involved in bone formation.
Copyright © 2010 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888414     DOI: 10.1016/j.matbio.2010.09.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  12 in total

1.  Sp1 upregulates the proximal promoter activity of the mouse collagen α1(XI) gene (Col11a1) in chondrocytes.

Authors:  Keijirou Watanabe; Mariko Hida; Takako Sasaki; Hiroyuki Yano; Kenji Kawano; Hidekatsu Yoshioka; Noritaka Matsuo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-10-20       Impact factor: 2.416

Review 2.  The genetics of bone mass and susceptibility to bone diseases.

Authors:  David Karasik; Fernando Rivadeneira; Mark L Johnson
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

3.  Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylation.

Authors:  Rayana L Bighetti-Trevisan; Luciana O Almeida; Larissa M S Castro-Raucci; Jonathan A R Gordon; Coralee E Tye; Gary S Stein; Jane B Lian; Janet L Stein; Adalberto L Rosa; Marcio M Beloti
Journal:  Biomater Adv       Date:  2021-11-13

4.  Sp7/Osterix Is Restricted to Bone-Forming Vertebrates where It Acts as a Dlx Co-factor in Osteoblast Specification.

Authors:  Hironori Hojo; Shinsuke Ohba; Xinjun He; Lick Pui Lai; Andrew P McMahon
Journal:  Dev Cell       Date:  2016-04-28       Impact factor: 12.270

Review 5.  How rare bone diseases have informed our knowledge of complex diseases.

Authors:  Mark L Johnson
Journal:  Bonekey Rep       Date:  2016-09-21

6.  Evaluate the effects of serum urate level on bone mineral density: a genome-wide gene-environment interaction analysis in UK Biobank cohort.

Authors:  Yao Yao; Xiaomeng Chu; Mei Ma; Jing Ye; Yan Wen; Ping Li; Bolun Cheng; Shiqiang Cheng; Lu Zhang; Li Liu; Xin Qi; Chujun Liang; Om Prakash Kafle; Cuiyan Wu; Sen Wang; Xi Wang; Yujie Ning; Feng Zhang
Journal:  Endocrine       Date:  2021-05-27       Impact factor: 3.633

7.  Intramembranous bone healing process subsequent to tooth extraction in mice: micro-computed tomography, histomorphometric and molecular characterization.

Authors:  Andreia Espindola Vieira; Carlos Eduardo Repeke; Samuel de Barros Ferreira Junior; Priscila Maria Colavite; Claudia Cristina Biguetti; Rodrigo Cardoso Oliveira; Gerson Francisco Assis; Rumio Taga; Ana Paula Favaro Trombone; Gustavo Pompermaier Garlet
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

8.  Aberrant gene expression profiles, during in vitro osteoblast differentiation, of telomerase deficient mouse bone marrow stromal stem cells (mBMSCs).

Authors:  Hamid Saeed; Mehwish Iqtedar
Journal:  J Biomed Sci       Date:  2015-01-30       Impact factor: 8.410

Review 9.  Recent Advances of Osterix Transcription Factor in Osteoblast Differentiation and Bone Formation.

Authors:  Qian Liu; Mao Li; Shiyi Wang; Zhousheng Xiao; Yuanyuan Xiong; Guangwei Wang
Journal:  Front Cell Dev Biol       Date:  2020-12-15

10.  Regulation of the osterix (Osx, Sp7) promoter by osterix and its inhibition by parathyroid hormone.

Authors:  Richard Barbuto; Jane Mitchell
Journal:  J Mol Endocrinol       Date:  2013-06-18       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.